NJ State Employees Deferred Compensation Plan’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,100
Closed -$216K 483
2023
Q4
$216K Hold
7,100
0.03% 422
2023
Q3
$225K Hold
7,100
0.03% 403
2023
Q2
$290K Hold
7,100
0.04% 380
2023
Q1
$265K Hold
7,100
0.04% 394
2022
Q4
$248K Hold
7,100
0.04% 393
2022
Q3
$397K Buy
+7,100
New +$397K 0.07% 293